Adalimumab in Treating Refractory Livedoid Vasculopathy

Livedoid vasculopathy is a chronic, recurrent skin disorder. It seriously affects the quality of patients’ life. However, the pathogenesis has not been fully identified yet. Here, this retrospective study describes the successful use of anti-TNF-α agent adalimumab in three cases of refractory livedo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiao-Wen, Zheng, Huan-Xin, Wang, Meng-Lei, He, Wan-Mei, Feng, Mei-Xin, Zeng, Kang, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026708/
https://www.ncbi.nlm.nih.gov/pubmed/35455298
http://dx.doi.org/10.3390/vaccines10040549
_version_ 1784691180570673152
author Huang, Xiao-Wen
Zheng, Huan-Xin
Wang, Meng-Lei
He, Wan-Mei
Feng, Mei-Xin
Zeng, Kang
Li, Li
author_facet Huang, Xiao-Wen
Zheng, Huan-Xin
Wang, Meng-Lei
He, Wan-Mei
Feng, Mei-Xin
Zeng, Kang
Li, Li
author_sort Huang, Xiao-Wen
collection PubMed
description Livedoid vasculopathy is a chronic, recurrent skin disorder. It seriously affects the quality of patients’ life. However, the pathogenesis has not been fully identified yet. Here, this retrospective study describes the successful use of anti-TNF-α agent adalimumab in three cases of refractory livedoid vasculopathy, which has not been reported previously. In addition, we provide some clinical evidence that adalimumab therapy is efficient in improving skin lesions and relieving the pain of livedoid vasculopathy.
format Online
Article
Text
id pubmed-9026708
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90267082022-04-23 Adalimumab in Treating Refractory Livedoid Vasculopathy Huang, Xiao-Wen Zheng, Huan-Xin Wang, Meng-Lei He, Wan-Mei Feng, Mei-Xin Zeng, Kang Li, Li Vaccines (Basel) Communication Livedoid vasculopathy is a chronic, recurrent skin disorder. It seriously affects the quality of patients’ life. However, the pathogenesis has not been fully identified yet. Here, this retrospective study describes the successful use of anti-TNF-α agent adalimumab in three cases of refractory livedoid vasculopathy, which has not been reported previously. In addition, we provide some clinical evidence that adalimumab therapy is efficient in improving skin lesions and relieving the pain of livedoid vasculopathy. MDPI 2022-04-01 /pmc/articles/PMC9026708/ /pubmed/35455298 http://dx.doi.org/10.3390/vaccines10040549 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Huang, Xiao-Wen
Zheng, Huan-Xin
Wang, Meng-Lei
He, Wan-Mei
Feng, Mei-Xin
Zeng, Kang
Li, Li
Adalimumab in Treating Refractory Livedoid Vasculopathy
title Adalimumab in Treating Refractory Livedoid Vasculopathy
title_full Adalimumab in Treating Refractory Livedoid Vasculopathy
title_fullStr Adalimumab in Treating Refractory Livedoid Vasculopathy
title_full_unstemmed Adalimumab in Treating Refractory Livedoid Vasculopathy
title_short Adalimumab in Treating Refractory Livedoid Vasculopathy
title_sort adalimumab in treating refractory livedoid vasculopathy
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026708/
https://www.ncbi.nlm.nih.gov/pubmed/35455298
http://dx.doi.org/10.3390/vaccines10040549
work_keys_str_mv AT huangxiaowen adalimumabintreatingrefractorylivedoidvasculopathy
AT zhenghuanxin adalimumabintreatingrefractorylivedoidvasculopathy
AT wangmenglei adalimumabintreatingrefractorylivedoidvasculopathy
AT hewanmei adalimumabintreatingrefractorylivedoidvasculopathy
AT fengmeixin adalimumabintreatingrefractorylivedoidvasculopathy
AT zengkang adalimumabintreatingrefractorylivedoidvasculopathy
AT lili adalimumabintreatingrefractorylivedoidvasculopathy

Ejemplares similares